OBJECTIVE: Natural killer (NK) cells are important in innate immune responses to bacterial and viral pathogens. HIV-1 infection is associated with opportunistic bacterial infections and with microbial translocation, but the nature of the NK cell response to bacteria during HIV-1 infection has not been studied extensively. The objective of this study was to compare NK cell responses to bacteria in HIV-1-infected versus that in uninfected individuals. METHODS: Multicolor flow cytometry was used to evaluate the ability of blood NK cell subsets (CD56CD16, CD56CD16, and CD56CD16) from treated, virally suppressed, and untreated viremic subjects with chronic HIV-1 infection and uninfected controls, to secrete interferon gamma (IFN-γ) in response to the in vitro stimulation of peripheral blood mononuclear cells with heat-killed commensal Escherichia coli or pathogenic Salmonella typhimurium. RESULTS: All 3 NK cell subsets produced IFN-γ in response to bacteria, but CD56CD16 NK cells were least responsive. Untreated HIV-1-infected donors had increased frequencies of CD56CD16 NK cells and lower overall frequencies of IFN-γ-producing NK cells responding to E. coli and S. typhimurium than did NK cells from uninfected donors. These NK cell defects were not fully restored in antiretroviral therapy-treated donors. Monocytes were necessary for NK cells to respond to bacteria, but the HIV-associated defect was intrinsic to NK cells because the addition of normal monocytes did not restore IFN-γ production in response to bacteria. CONCLUSIONS: Functional defects and numeric alterations of NK cell subsets lead to decreased frequencies of bacteria-reactive, IFN-γ-producing NK cells in HIV-1-infected subjects, even those on antiretroviral therapy.
OBJECTIVE: Natural killer (NK) cells are important in innate immune responses to bacterial and viral pathogens. HIV-1 infection is associated with opportunistic bacterial infections and with microbial translocation, but the nature of the NK cell response to bacteria during HIV-1 infection has not been studied extensively. The objective of this study was to compare NK cell responses to bacteria in HIV-1-infected versus that in uninfected individuals. METHODS: Multicolor flow cytometry was used to evaluate the ability of blood NK cell subsets (CD56CD16, CD56CD16, and CD56CD16) from treated, virally suppressed, and untreated viremic subjects with chronic HIV-1 infection and uninfected controls, to secrete interferon gamma (IFN-γ) in response to the in vitro stimulation of peripheral blood mononuclear cells with heat-killed commensal Escherichia coli or pathogenic Salmonella typhimurium. RESULTS: All 3 NK cell subsets produced IFN-γ in response to bacteria, but CD56CD16 NK cells were least responsive. Untreated HIV-1-infected donors had increased frequencies of CD56CD16 NK cells and lower overall frequencies of IFN-γ-producing NK cells responding to E. coli and S. typhimurium than did NK cells from uninfected donors. These NK cell defects were not fully restored in antiretroviral therapy-treated donors. Monocytes were necessary for NK cells to respond to bacteria, but the HIV-associated defect was intrinsic to NK cells because the addition of normal monocytes did not restore IFN-γ production in response to bacteria. CONCLUSIONS: Functional defects and numeric alterations of NK cell subsets lead to decreased frequencies of bacteria-reactive, IFN-γ-producing NK cells in HIV-1-infected subjects, even those on antiretroviral therapy.
Authors: Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld Journal: Blood Date: 2005-07-07 Impact factor: 22.113
Authors: Veronica D Gonzalez; Karolin Falconer; Niklas K Björkström; Kim G Blom; Ola Weiland; Hans-Gustaf Ljunggren; Annette Alaeus; Johan K Sandberg Journal: J Immunol Date: 2009-10-21 Impact factor: 5.422
Authors: Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski Journal: J Immunol Date: 2012-06-27 Impact factor: 5.422
Authors: Anne Nolting; Anne-Sophie Dugast; Suzannah Rihn; Rutger Luteijn; Mary F Carrington; Katherine Kane; Stephanie Jost; Ildiko Toth; Ellen Nagami; Gerd Faetkenheuer; Pia Hartmann; Marcus Altfeld; Galit Alter Journal: Virology Date: 2010-07-29 Impact factor: 3.616
Authors: Lisbeth N Fink; Louise H Zeuthen; Hanne R Christensen; Barbara Morandi; Hanne Frøkiaer; Guido Ferlazzo Journal: Int Immunol Date: 2007-10-20 Impact factor: 4.823
Authors: D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki Journal: Oral Dis Date: 2016-04 Impact factor: 3.511
Authors: Stephanie M Dillon; Moriah J Castleman; Daniel N Frank; Gregory L Austin; Sara Gianella; Andrew C Cogswell; Alan L Landay; Edward Barker; Cara C Wilson Journal: J Acquir Immune Defic Syndr Date: 2017-12-01 Impact factor: 3.731
Authors: Jennifer A Juno; Andrew T Stalker; Jillian Lm Waruk; Julius Oyugi; Makobu Kimani; Francis A Plummer; Joshua Kimani; Keith R Fowke Journal: Retrovirology Date: 2015-02-13 Impact factor: 4.602
Authors: Maryse A Wiewel; Michaëla A Huson; Lonneke A van Vught; Arie J Hoogendijk; Peter M C Klein Klouwenberg; Janneke Horn; René Lutter; Olaf L Cremer; Marcus J Schultz; Marc J Bonten; Tom van der Poll Journal: Crit Care Date: 2016-10-10 Impact factor: 9.097
Authors: Dominik J Kaczmarek; Pavlos Kokordelis; Benjamin Krämer; Andreas Glässner; Franziska Wolter; Felix Goeser; Philipp Lutz; Carolynne Schwarze-Zander; Christoph Boesecke; Christian P Strassburg; Jürgen K Rockstroh; Ulrich Spengler; Jacob Nattermann Journal: PLoS One Date: 2017-04-05 Impact factor: 3.240
Authors: Jon J Kibbie; Stephanie M Dillon; Tezha A Thompson; Christine M Purba; Martin D McCarter; Cara C Wilson Journal: Immunobiology Date: 2021-07-30 Impact factor: 3.152
Authors: Michael Allen; Cedric Bailey; Ian Cahatol; Levi Dodge; Jay Yim; Christine Kassissa; Jennifer Luong; Sarah Kasko; Shalin Pandya; Vishwanath Venketaraman Journal: Front Immunol Date: 2015-10-05 Impact factor: 7.561
Authors: Jennifer Leigh Townsend; Satish Shanbhag; John Hancock; Kathryn Bowman; Ank E Nijhawan Journal: Open Forum Infect Dis Date: 2015-04-15 Impact factor: 3.835
Authors: Juliana Reis Machado; Marcos Vinícius da Silva; Camila Lourencini Cavellani; Marlene Antônia dos Reis; Maria Luiza Gonçalves dos Reis Monteiro; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Corrêa Journal: Biomed Res Int Date: 2014-09-15 Impact factor: 3.411
Authors: Michaëla A M Huson; Arie J Hoogendijk; Alex F de Vos; Martin P Grobusch; Tom van der Poll Journal: J Int AIDS Soc Date: 2016-05-16 Impact factor: 5.396